Publication: Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure.
No Thumbnail Available
Identifiers
Date
2022-01-29
Authors
Perez-Belmonte, Luis M
Miramontes-Gonzalez, Jose P
Osuna-Sanchez, Julio
Lara, Jose P
Gómez-Huelgas, Ricardo
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
American Geriatrics Society
Metrics
Export
Abstract
We greatly appreciate the comments from Ismayilovet al. 1 regarding our recent publication on the clinicalbenefits of empagliflozin in very old patients in the hospi-tal setting.
Description
MeSH Terms
Benzhydryl Compounds
Diabetes Mellitus, Type 2
Glucosides
Heart Failure
Humans
Diabetes Mellitus, Type 2
Glucosides
Heart Failure
Humans
DeCS Terms
Benzhydryl Compounds
Diabetes Mellitus, Type 2
Glucosides
Heart Failure
Humans
Diabetes Mellitus, Type 2
Glucosides
Heart Failure
Humans
CIE Terms
Keywords
Benzhydryl Compounds, Diabetes Mellitus, Type 2, Glucosides, Heart Failure
Citation
Pérez-Belmonte LM, Miramontes-González JP, Osuna-Sánchez J, Lara JP, Gómez-Huelgas R. Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure. J Am Geriatr Soc. 2022;70:1585-1589